Vimta Labs
Vimta Labs Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Vimta Labs
Start SIPVimta Labs Investment Rating
-
Master Rating:
-
Vimta Labs has an operating revenue of Rs. 318.19 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 20% is great, ROE of 17% is exceptional. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 10% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 16% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 154 indicates it belongs to a poor industry group of Medical-Services and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 81 | 76 | 79 | 79 | 74 |
| Operating Expenses Qtr Cr | 57 | 55 | 54 | 55 | 51 |
| Operating Profit Qtr Cr | 24 | 21 | 25 | 24 | 23 |
| Depreciation Qtr Cr | 8 | 8 | 8 | 7 | 7 |
| Interest Qtr Cr | 0 | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 4 | 4 | 4 | 5 | 4 |
| Net Profit Qtr Cr | 12 | 10 | 13 | 12 | 12 |
Vimta Labs Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹403.3
- 50 Day
- ₹384.06
- 100 Day
- ₹376.07
- 200 Day
- ₹373.49
- 20 Day
- ₹399.71
- 50 Day
- ₹377.53
- 100 Day
- ₹359
- 200 Day
- ₹381.32
Vimta Labs Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹424.4 |
| Second Resistance | ₹428.7 |
| Third Resistance | ₹433.4 |
| RSI | 65.48 |
| MFI | 77.78 |
| MACD Single Line | 11.25 |
| MACD | 11.96 |
| Support | |
|---|---|
| First Resistance | ₹415.4 |
| Second Resistance | ₹410.7 |
| Third Resistance | ₹406.4 |
Vimta Labs Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 51,211 | 2,630,709 | 51.37 |
| Week | 38,158 | 1,975,429 | 51.77 |
| 1 Month | 57,517 | 2,634,268 | 45.8 |
| 6 Month | 52,878 | 2,521,762 | 47.69 |
Vimta Labs Result Highlights
Vimta Labs Synopsis
NSE-Medical-Services
Vimta Labs Ltd. belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 315.12 Cr. and Equity Capital is Rs. 4.43 Cr. for the Year ended 31/03/2023. Vimta Labs Ltd. is a Public Limited Listed company incorporated on 16/11/1990 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1990PLC011977 and registration number is 011977.| Market Cap | 930 |
| Sales | 315 |
| Shares in Float | 1.39 |
| No of funds | 17 |
| Yield | 0.48 |
| Book Value | 3.29 |
| U/D Vol ratio | 1.9 |
| LTDebt / Equity | 4 |
| Alpha | 0.05 |
| Beta | 1.12 |
Vimta Labs
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 37.24% | 37.25% | 37.46% | 37.46% |
| Mutual Funds | 1.48% | 1.48% | 1.48% | 1.48% |
| Foreign Portfolio Investors | 2.25% | 2.28% | 0.49% | 0.35% |
| Individual Investors | 25.19% | 25.07% | 26.79% | 26.99% |
| Others | 33.84% | 33.92% | 33.78% | 33.72% |
Vimta Labs Management
| Name | Designation |
|---|---|
| Dr. Sivalinga Prasad Vasireddi | Non Executive Chairman |
| Mr. Harita Vasireddi | Managing Director |
| Mr. Harriman Vungal | Executive Director - Operations |
| Mr. Satya Sreenivas Neerukonda | Executive Director |
| Dr. Yadagiri R Pendri | Independent Director |
| Mrs. Prameela Rani Yalamanchili | Independent Director |
| Mr. Sanjay Dave | Independent Director |
| Mr. Purnachandra Rao Gutta | Independent Director |
Vimta Labs Forecast
Price Estimates
Vimta Labs Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-03 | Audited Results & Final Dividend | |
| 2023-01-27 | Quarterly Results | |
| 2022-10-27 | Quarterly Results | |
| 2022-07-25 | Quarterly Results | |
| 2022-05-12 | Audited Results & Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2022-06-18 | FINAL | Rs.2.00 per share(100%)Dividend |
| 2021-06-28 | FINAL | Rs.2.00 per share(100%)Dividend |
Vimta Labs FAQs
What is Share Price of Vimta Labs ?
Vimta Labs share price is ₹417 As on 10 June, 2023 | 16:36
What is the Market Cap of Vimta Labs ?
The Market Cap of Vimta Labs is ₹924.3 Cr As on 10 June, 2023 | 16:36
What is the P/E ratio of Vimta Labs ?
The P/E ratio of Vimta Labs is 19.2 As on 10 June, 2023 | 16:36
What is the PB ratio of Vimta Labs ?
The PB ratio of Vimta Labs is 3.3 As on 10 June, 2023 | 16:36